Literature DB >> 8381249

Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.

M S Green1, R Handsher, D Cohen, J L Melnick, R Slepon, E Mendelsohn, Y L Danon.   

Abstract

During the 1988 type 1 polio outbreak in Israel, most cases occurred in previously vaccinated subjects aged 11-30 years, suggesting a possible age-related immunity deficit against the wild virus responsible for the outbreak. We examined type 1 poliovirus neutralizing antibody titres against the Sabin strain, the standard wild strain (Mahoney), the wild strain responsible for the 1988 outbreak and a previous wild strain from the region, on frozen sera drawn prior to the mass vaccination campaign from subjects aged 6 to 40 years. Response to vaccination with oral poliovaccine (OPV) was examined in a subgroup aged 18-40 years. At all ages, the highest antibody titres prior to the outbreak were against the Sabin strain. Geometric mean titres (GMTs) against both the Sabin strain and the wild Mahoney strain were significantly higher in the age groups 6-7, 12-13 and 30-40 years compared with the 18-29-year-olds. For the other wild strains, the GMT for those aged 30-40 years was significantly and substantially higher than in the other age groups, followed by the 12-13- and 6-7-year-olds and lowest in those aged 18-29 years. Following vaccination with OPV in subgroups aged 18-29 and 30-40 years, GMTs against Sabin and all wild strains were similar to each other and in both age groups. These findings suggest that there was a relative immunity gap against the wild type 1 strains in the age group that lacked prior exposure to wild virus and had received the last OPV dose more than 17 years previously.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381249     DOI: 10.1016/0264-410x(93)90342-u

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long-term environmental surveillance.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; B Abramovitz; A Mates; E Mendelson
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

3.  A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts.

Authors:  F Pregliasco; V Minolfi; A Boschin; A Andreassi; M L Profeta
Journal:  Eur J Epidemiol       Date:  1995-12       Impact factor: 8.082

4.  Successes and shortcomings of polio eradication: a transmission modeling analysis.

Authors:  Bryan T Mayer; Joseph N S Eisenberg; Christopher J Henry; M Gabriela M Gomes; Edward L Ionides; James S Koopman
Journal:  Am J Epidemiol       Date:  2013-04-16       Impact factor: 4.897

5.  Genomic characterization of human and environmental polioviruses isolated in Albania.

Authors:  M Divizia; L Palombi; E Buonomo; D Donia; V Ruscio; M Equestre; L Leno; A Panà; A M Degener
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

6.  Resolution of the pathways of poliovirus type 1 transmission during an outbreak.

Authors:  L M Shulman; R Handsher; C F Yang; S J Yang; J Manor; A Vonsover; Z Grossman; M Pallansch; E Mendelson; O M Kew
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 7.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Acquisition of immunity in mothers of infants administered trivalent oral poliovirus vaccine.

Authors:  R Dagan; D Fraser; R Handsher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

Review 9.  Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.

Authors:  Y Ghendon; S E Robertson
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.